Experimental strategies to reverse chronic renal disease

Blood Purif. 2004;22(5):440-5. doi: 10.1159/000080790. Epub 2004 Sep 9.


Progression of chronic nephropathies still represents a major challenge for clinical nephrologists. Specific therapies that prevent patients from requiring dialysis or transplantation are still not available. However, recent experimental studies have demonstrated that regression of advanced lesions in the kidney can be achieved. This review summarizes the recent therapeutic advances using experimental models that might translate into novel human therapies to prevent, or significantly delay, requirement of renal replacement therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Hepatocyte Growth Factor / physiology
  • Humans
  • Kidney Failure, Chronic / etiology
  • Kidney Failure, Chronic / therapy*
  • Regeneration
  • Renin-Angiotensin System / drug effects
  • Transforming Growth Factor beta / physiology


  • Transforming Growth Factor beta
  • Hepatocyte Growth Factor